Ovarian hyperstimulation syndroe (OHSS) is an iatrogenic complication of ovulation induction agents used for ovulatory dysfunction.
This reports is to review the records of 10 patients who were hospitalized for the management of severe ovarian hyperstimulation syndrome from Septermber, 1990 to June, 1994. Retrospectively.
Treatment was conservative with infusion of plasma volume expander and electrolyte solutions. In 3 cases, transvaginal paracentesis was performed for symptomatic relief.
@ES The results were as follows:
@EN 1. The regimens for controlled ovarian hyperstimulation were hMG/hCG in 9 cases, CC/Hmg/hCG in one case.
2. In all cases, abdominal pain, ovarian enlargement, ascites and weight gain were presented. There was no case of thromboembolism.
3. The mean age of 10 patients was 27 years. The duration from hCG injection to hospital admission was 15 days and the mean hopsital day was 12 days. The mean preovulatory serum E2 level has 9760.6 pg/ml.
4. In 3 cases, paracentesis was performed under the transvaginal ultrasonographic guidances. An average amount of paracentesis per one time was 1660 ml.
5. 9 patients (90%) including 2 twin gestations were associated with conception.
As a conclusion, severe OHSS was recevered with conservative treatment, including fluid therapy and correction of electrolyte imbalance, and transvaginal ultrasonography-guided paracentesis without any serious complication.
|